Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Gaal; Jozsef
Address:
Budapest, HU
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8226968 Liposome composition July 24, 2012
The invention relates to a liposomal composition, containing a citrus type (Aurantioideae) essential oil of pharmaceutical grade 0.5-5.0 part by weight; lavender oil of pharmaceutical grade 0.5-5.0 part by weight; vitamin E 0.1-1.5 part by weight; vitamin A 0.1-1.5 part by weight; ca
5888536 Liposome composition containing selegilin March 30, 1999
This invention provides liposomic composition, containing as active ingredient (-)-N-.alpha.-dimethyl-N-(2-propynylphenylethylamine) (selegilin) and/or salt thereof. This composition contains: 0.1-40% by weight of selegilin and/or a salt thereof, 2 to 40% by weight of lipids, prefera
5589513 Pharmaceutical composition and process for the preparation thereof December 31, 1996
The invention relates to two phase pharmaceutical compositions comprising as active ingredient a MAO inhibitor and an uptake inhibitor together with usual pharmaceutical auxiliaries. The compositions can be used for the treatment of neurodegenerative diseases. As active ingredient option
5403840 Inclusion complexes of N-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodex April 4, 1995
The invention relates to inclusion complexes of N-ethoxycarbonyl-3-morpholino-sydnonimine or its salts formed with a cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same.The inclusion complex of N-ethoxycarbonyl-3-morpholino-sydnonimine or its
5298496 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for March 29, 1994
The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same.The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin der
5218117 Process for preparing isoquinoline compounds June 8, 1993
The invention relates to novel compounds of the general formula (I), ##STR1## The compounds of the invention antagonize the effects of constrictive mediators, e.g. histamine, acetylcholine or serotonin; they show an antiallergic action and possess an antiinflammatory effect. Thus, th
5179089 Isoquinoline compounds, compositions and use January 12, 1993
The invention relates to novel compounds of the general formula (I), ##STR1## wherein R means hydrogen or a straight or branched chain C.sub.1-6 alkoxy group;R.sup.1 stands for hydrogen or a straight or branched chain C.sub.1-6 alkyl group;R.sup.2 represents hydrogen or a straight or
4851416 Berban derivatives as .alpha..sub.2 -adrenergic antagonists July 25, 1989
The invention relates to novel racemic or optically active berban derivatives of the formula (I) ##STR1## wherein R.sup.1 and R.sup.2 represent independently from the other a hydroxyl, straight or branched chain alkoxy group 1 to 6 carbon atoms or R.sup.1 and R.sup.2 together rep










 
 
  Recently Added Patents
Integrated circuit packaging system with interconnects and method of manufacture thereof
Hydrating lounge chair
Method of manufacturing semiconductor devices using ion implantation
Linear book scanner
Messenger bag
Electrode for a plasma torch
Transitional replacement of operations performed by a central hub
  Randomly Featured Patents
Magnetic toy
Automatic extractor
Method for forming ferroelectric memory device
Dial-down mechanism for wind-up pen
Method for the production of cement clinker low in sulphur
Ampoule breaker
Phase synchronization pull-in system in bit error detecting apparatus
Gun locking device
Pipeline analog-to-digital converter
Projectile, such as a shell, which is equipped with a bulkhead shield